Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +19,900.00% | -.--% | -.--% |
2017 | Proto Script Pharmaceutical Enters Partnership with PAKmed | CI |
2016 | Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D | CI |
Sales 2015 | 881K 73.49M | Sales 2016 | 789K 65.78M | Capitalization | 311M 25.9B |
---|---|---|---|---|---|
Net income 2015 | - 0 | Net income 2016 | -7M -584M | EV / Sales 2015 * | - |
Net Debt 2015 | 27.07K 2.26M | Net Debt 2016 | 47.78K 3.98M | EV / Sales 2016 | 394 x |
P/E ratio 2015 * |
-
| P/E ratio 2016 |
-41.4
x | Employees | 13 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 89.82% |
1 day | +19,900.00% | ||
6 months | -96.00% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Rico
CEO | Chief Executive Officer | 56 | 29/16/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michelle Rico
CEO | Chief Executive Officer | 56 | 29/16/29 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 11.38K | |
+10.55% | 67.6B | |
+11.64% | 18.21B | |
+9.40% | 13.37B | |
+16.53% | 9.94B | |
-32.90% | 5.74B | |
-10.98% | 5.57B | |
-4.09% | 4.91B | |
-4.83% | 4.87B | |
0.00% | 4.3B |
- Stock Market
- Equities
- PSCR Stock